GIALLONGO, CESARINA
 Distribuzione geografica
Continente #
NA - Nord America 4.747
EU - Europa 2.642
AS - Asia 2.227
AF - Africa 427
SA - Sud America 374
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.424
Nazione #
US - Stati Uniti d'America 4.637
IT - Italia 1.655
SG - Singapore 984
CN - Cina 754
CI - Costa d'Avorio 328
BR - Brasile 319
IE - Irlanda 289
VN - Vietnam 154
UA - Ucraina 136
KR - Corea 115
DE - Germania 103
RU - Federazione Russa 100
CA - Canada 75
GB - Regno Unito 65
IN - India 57
FI - Finlandia 55
SN - Senegal 49
FR - Francia 44
SE - Svezia 42
JP - Giappone 38
PL - Polonia 30
MX - Messico 29
NL - Olanda 29
AR - Argentina 25
CZ - Repubblica Ceca 23
HK - Hong Kong 19
BD - Bangladesh 17
BJ - Benin 16
BE - Belgio 15
ES - Italia 15
CH - Svizzera 13
EC - Ecuador 13
ZA - Sudafrica 12
IL - Israele 8
LB - Libano 8
TR - Turchia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
IQ - Iraq 7
NG - Nigeria 7
ID - Indonesia 6
GR - Grecia 5
IR - Iran 5
LT - Lituania 5
MA - Marocco 5
AT - Austria 4
AU - Australia 4
NP - Nepal 4
PK - Pakistan 4
PY - Paraguay 4
TN - Tunisia 4
AL - Albania 3
KZ - Kazakistan 3
NO - Norvegia 3
OM - Oman 3
SA - Arabia Saudita 3
TH - Thailandia 3
BO - Bolivia 2
CL - Cile 2
CO - Colombia 2
JO - Giordania 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
MK - Macedonia 1
NI - Nicaragua 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.424
Città #
Dallas 1.291
Santa Clara 653
Singapore 599
Catania 457
Chandler 453
Abidjan 327
Chicago 292
Dublin 285
Hefei 227
Ashburn 213
Jacksonville 156
Beijing 142
Boardman 123
Los Angeles 121
Seoul 115
Civitanova Marche 91
Florence 85
Houston 79
Cambridge 68
Lawrence 68
Rome 65
Andover 64
Milan 56
Dakar 49
Palermo 49
Dong Ket 44
Toronto 44
Buffalo 43
Munich 43
Nanjing 42
Moscow 40
New York 40
Des Moines 36
Ho Chi Minh City 35
São Paulo 35
Messina 29
Warsaw 29
Hanoi 27
Bari 26
Bronte 26
Misterbianco 26
Bremen 25
Wilmington 24
Tokyo 23
Council Bluffs 20
Lappeenranta 20
The Dalles 20
Brno 19
Helsinki 19
Hong Kong 19
Saint Petersburg 19
San Mateo 19
Falls Church 18
Nanchang 18
Shenyang 17
Washington 17
Cotonou 16
Turku 16
Columbus 15
Denver 15
Paris 15
Amsterdam 14
Brooklyn 14
Chennai 14
Dearborn 14
Fukuoka 14
Brussels 13
Turin 13
Augusta 12
Boston 12
Hebei 12
Kochi 12
Seattle 12
Stockholm 12
Ottawa 11
Poplar 11
Changsha 10
Johannesburg 10
Naples 10
Aci Catena 9
Guangzhou 9
Jiaxing 9
London 9
Mexico City 9
Montreal 9
Querétaro 9
Acireale 8
Atlanta 8
Belpasso 8
Mumbai 8
Orem 8
Tianjin 8
Charlotte 7
Genoa 7
Hanover 7
Mascalucia 7
Ragusa 7
Rio de Janeiro 7
San Giovanni la Punta 7
Abuja 6
Totale 7.453
Nome #
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 237
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 193
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload 189
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 181
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 173
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance 163
Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing 163
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells. 160
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 158
Biological properties of itraconazole-SLN 158
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 154
Clobetasol modulates adult neural stem cell growth via canonical hedgehog pathway activation 152
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 150
A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells 147
Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib 142
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis 140
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection 140
Focus on Osteosclerotic Progression in Primary Myelofibrosis 134
Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients 127
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 126
Hedgehog signaling pathways in multiple myeloma 126
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. 124
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 123
Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma 122
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 121
Biological properties of itraconazole-SLNs 121
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells 119
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 119
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 117
Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential 117
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 116
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 116
Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype 115
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 115
Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells 115
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION 114
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 114
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 112
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib 111
Effect of lipoic acid on the biochemical mechanisms of resistance to bortezomib in SH-SY5Y neuroblastoma cells 109
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients 108
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 108
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 105
Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells 104
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 103
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors 103
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 102
The Heme Oxygenase System in Hematological Malignancies 100
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 100
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 99
CIRCULATING ARGINASE-1 IN SERUM IS A NOVEL BIO-MARKERIN HODGKIN LYMPHOMA 99
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment 98
The Role of Epigenetics in Neuroinflammatory-Driven Diseases 97
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 96
Correction to: Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models (Antioxidants, (2022), 11, 8, (1596), 10.3390/antiox11081596) 96
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 95
Pericytes in microvessels: From “mural” function to brain and retina regeneration 93
Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models 92
Nuclear translocation of Heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells 92
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 92
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 90
Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project 88
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 87
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 87
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 87
Effects of imatinib mesylate in osteoblastogenesis 85
Myeloid-derived suppressor cells in Chronic myeloid leukemia 85
Correction to: Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 84
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 84
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 84
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 82
Neuroactive molecules and growth factors modulate cytoskeletal protein expression during astroglial cell proliferation and differentiation in culture 82
Targeted metabolomic evaluation of peripheral blood mononucleated cells from patients with PMM2-CDG 81
Modulation of extracellular signal-related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol-pretreated astrocyte cultures treated with competence and progression growth factors 81
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview 81
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 78
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment 76
MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA 74
Rebalancing Immune Interactions within the Brain-Spleen Axis Mitigates Neuroinflammation in an Aging Mouse Model of Alzheimer’s Disease 72
Ixazomib inhibits osteoclastogenesis and promotes osteogenic differentiation in vitro 69
GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS ARE INCREASED IN MULTIPLE MYELOMA DUE TO IMMUNOLOGICAL DYSREGULATION OF MESENCHYMAL STEM CELLS 69
OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE 68
Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients 66
Pituitary Adenylate Cyclase-Activating Polypeptide Protects Corneal Epithelial Cells against UV-B-Induced Apoptosis via ROS/JNK Pathway Inhibition 65
Proteasome inhibitors as a possible therapy for SARS-CoV-2 63
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome 63
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells 62
IMPAIRED NEUTROPHIL FUNCTION IN PATIENTS WITH ACUTE LEUKEMIA 62
Uveal melanoma cells elicit retinal pericyte phenotypical and biochemical changes in an in vitro model of coculture 62
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients 61
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma. 61
Monocytic myeloid derived suppressor cells in hematological malignancies 61
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 61
MESENCHYMAL STEM CELLS FROM CML PATIENTS REGULATE MYELOID DERIVED SUPPRESSOR CELLS ACTIVATION 60
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells 60
The Pleiotropic Effects of Fumarate: From Mitochondrial Respiration to Epigenetic Rewiring and DNA Repair Mechanisms 58
LENALIDOMIDE TREATMENT IS ABLE TO RESTORE REGULATORY T CELLS IN MULTIPLE MYELOMA PATIENTS 58
Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity 56
The Role of Inflammation and Inflammasome in Myeloproliferative Disease 56
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 55
Totale 10.379
Categoria #
all - tutte 35.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.305


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021361 0 0 0 0 111 16 61 11 30 7 49 76
2021/2022653 41 77 10 4 116 26 101 49 51 31 18 129
2022/20231.368 96 112 40 144 111 188 19 237 267 44 71 39
2023/2024928 55 140 39 40 47 203 40 88 4 25 168 79
2024/20252.886 42 456 155 198 522 357 157 136 175 226 242 220
2025/20263.663 417 883 1.051 479 833 0 0 0 0 0 0 0
Totale 10.627